Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/14/11 → 10/24/14 |
Funding
- pSivida Corp: $135,238.00
A Phase 1, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release (SR) Insert in Patients with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension
- Moore, Daniel (PI)
- Deokule, Sunil (Former PI)